In Vivo Star Anti-Mouse NK1.1 Antibody

Cat # Size Price Quantity
5156011 mg$160
5156025 mg$500
51560325 mg$1300

Product Details


ClonePK136
ApplicationELISA, WB, Flow cytometry, IHC, ICC, animal model study
Host SpeciesCHO cells
ReactivityMouse
FormatLiquid
Target NameNK-1.1, CD161, NKR-P1C, NKR-P1B, Ly-55
Product DescriptionIn Vivo Grade Recombinant Anti-mouse NK1.1 Monoclonal Antibody
IsotypeMouse IgG2a Kappa
Antibody TypeRecombinant
Regulatory StatusRUO
Purity>95% by reducing SDS-PAGE
Endotoxin< 1 EU per 1 mg of the protein by the LAL method.
Storage Conditions4ºC
GradeIn vivo
Recommended UsageThis product is suitable for in vivo animal use. Optimal amounts need to be determined empirically for each experiment.
RRIDAB_3739432
Research AreasNK cells, MAIT cells, Th17 cells, Inflammation
See All FormatsClone PK136

Background Information


NK1.1, also known as CD161c or NKR-P1C, is a defining cell surface marker used extensively in immunology to identify Natural Killer (NK) cells and a subset of T cells known as NKT cells in specific strains of mice. It belongs to the C-type lectin-like receptor superfamily and plays a significant role in the regulation of NK cell function. Unlike many other immune receptors that are conserved across all members of a species, NK1.1 expression is strain-dependent; it is notably present in C57BL/6 mice but absent in BALB/c and SJL mice, which express allelic variants (NKR-P1B) that are not recognized by the standard anti-NK1.1 monoclonal antibody (clone PK136).

Structurally, NK1.1 is a type II transmembrane glycoprotein that exists as a disulfide-linked homodimer. It contains an extracellular C-type lectin-like domain (CTLD), a transmembrane region, and a cytoplasmic tail. Functionally, NK1.1 acts as an activating receptor. Its cytoplasmic tail associates with the Fc receptor gamma chain (FcRγ), an adaptor protein containing an Immunoreceptor Tyrosine-based Activation Motif (ITAM). When NK1.1 binds to its ligand, this association triggers a signaling cascade involving Syk kinase, leading to the release of cytotoxic granules (containing perforin and granzymes) and the production of cytokines like Interferon-gamma (IFN-γ), thereby promoting the killing of target cells.

The specific physiological ligand for NK1.1 (NKR-P1C) has been a subject of investigation, with research identifying members of the C-type lectin-related (Clr) family as key interaction partners. Specifically, NKR-P1C has been shown to bind to Clr-b (encoded by the Clec2d gene). This interaction is part of a complex system of "missing self" and "induced self" recognition, where NK cells monitor the health of host tissues. While the inhibitory receptor NKR-P1B also binds Clr-b to prevent autoimmunity, the activating NK1.1 receptor may help detect cells that have dysregulated Clr-b expression due to stress or infection.

In mouse research, NK1.1 is the "gold standard" marker for identifying NK cells in C57BL/6 mice, the most common background for genetic models. The anti-NK1.1 antibody (clone PK136) is widely used not only for flow cytometry staining but also for in vivo depletion studies. By injecting this antibody, researchers can selectively eliminate NK and NKT cells to study their specific contributions to tumor immunity, viral infections, and autoimmune diseases. However, because its expression is restricted to certain strains, researchers working with BALB/c mice must rely on other markers, such as CD49b (DX5), to identify NK cells.

Data Sheets


In Vivo Star Anti-Mouse NK1.1 Antibody TDS

Related Protocols


Direct ELISA Protocol

Western Blot Protocol

Flow Cytometry Protocol

Frequently Asked Questions


What are In Vivo Star Biofunctional Antibodies?
In Vivo Star antibodies are premium-grade monoclonal antibodies purified and formulated specifically for use in animal studies. Each lot is manufactured under stringent quality controls to ensure the low endotoxin levels, high purity, and functional activity required for reliable in vivo results.

How are these antibodies different from standard research antibodies (e.g., for Western blot or flow cytometry)?
Standard research antibodies are optimized for in vitro detection assays and may contain preservatives, carrier proteins (like BSA), or higher endotoxin levels unsuitable for injection. In Vivo Star antibodies are formulated in injectable-grade, azide-free, low-endotoxin buffers and validated for functional bioactivity in living systems rather than just antigen binding.

What endotoxin and purity specifications do these antibodies meet?
All In Vivo Star antibodies are tested and certified to meet low-endotoxin thresholds (typically <1 EU/mg, lot-dependent) using the LAL (Limulus Amebocyte Lysate) assay, and are purified to ≥95% purity by SEC-HPLC or SDS-PAGE. Exact specifications are provided on the Certificate of Analysis (CoA) for each lot.

Are these antibodies azide-free and carrier-free?
All In Vivo Star antibodies are formulated without sodium azide and without carrier proteins such as BSA or gelatin, since both can interfere with animal physiology or immune readouts during in vivo studies.

Do you provide isotype controls?
Matched isotype control antibodies (same host species, isotype, and formulation) are available upon request for most clones to support proper experimental controls.

How should In Vivo Star antibodies be stored and handled?
Store at 4°C for short-term use and avoid repeated freeze-thaw cycles, which can reduce bioactivity; aliquoting is recommended for long-term storage per the product-specific storage instructions on the Certificate of Analysis. Always confirm storage conditions and expiration on the CoA that accompanies each lot, as these can vary slightly by antibody.

Have a product or application question? Consult our FAQs or contact us.